TickerFactsScreenerDevelopers

SUPERNUS PHARMACEUTICALS, INC. (SUPN) — Revenue

Annual figures by fiscal year, from SEC filings.

2018: $408.90M2019: $392.75M2020: $520.40M2021: $579.77M2022: $667.24M2023: $607.52M2024: $661.82M2025: $718.95M$718.95M
2018Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$718.95M+8.6%
2024$661.82M+8.9%
2023$607.52M-8.9%
2022$667.24M+15.1%
2021$579.77M+11.4%
2020$520.40M+32.5%
2019$392.75M-3.9%
2018$408.90M—